<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>Insight数据库 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-26T20:26:31+08:00</updated>
  <subtitle>丁香园 Insight 数据库（db.dxy.cn），拥有申报、临床、上市、药企等 10 大核心数据。致力于分享医药行业政策解读、药企大事和药品申报情报等</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>复宏汉霖「阿达木单抗」即将获批，国产第 4 家</title>
    <updated>2020-11-26T17:29:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/sdgedld6IOgx4MXLsSFD_Q</id>
    <link href="https://mp.weixin.qq.com/s/sdgedld6IOgx4MXLsSFD_Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>大健康行业前两名：恒瑞医药、迈瑞医疗，胡润中国民企 500 强发榜</title>
    <updated>2020-11-26T17:29:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/UdhNBzqBxWRxrUCS1TX81w</id>
    <link href="https://mp.weixin.qq.com/s/UdhNBzqBxWRxrUCS1TX81w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>相约南京-肿瘤免疫治疗开发申报分享会 | 开启报名</title>
    <updated>2020-11-26T17:29:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/Q0kA5etV9vFdCkZBH_mXZw</id>
    <link href="https://mp.weixin.qq.com/s/Q0kA5etV9vFdCkZBH_mXZw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>30 家企业入围，重庆等 5 省市第一批药品集采拟中选结果公布</title>
    <updated>2020-11-26T17:29:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/XtY45pLNwQtkeQlUt0-R2Q</id>
    <link href="https://mp.weixin.qq.com/s/XtY45pLNwQtkeQlUt0-R2Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>降幅赶超国采！山东省 40 个品种集采报价流出</title>
    <updated>2020-11-25T16:50:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/-E06P7BQlIVPpzPIanYACg</id>
    <link href="https://mp.weixin.qq.com/s/-E06P7BQlIVPpzPIanYACg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>今日 4 个品种通过一致性评价，3 个为前三家</title>
    <updated>2020-11-25T16:50:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/rF6frIQYboB0A6s8IFpaew</id>
    <link href="https://mp.weixin.qq.com/s/rF6frIQYboB0A6s8IFpaew" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>重磅！国药集团新冠疫苗报上市</title>
    <updated>2020-11-25T16:50:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/TzWdQPVhT9lWhXfogtN--w</id>
    <link href="https://mp.weixin.qq.com/s/TzWdQPVhT9lWhXfogtN--w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>荣昌生物 c-Met 靶向 ADC 启动临床</title>
    <updated>2020-11-25T16:50:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/nOPydS_QueOk0qbKq8EESA</id>
    <link href="https://mp.weixin.qq.com/s/nOPydS_QueOk0qbKq8EESA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>君实生物 TIGIT 单抗临床申请获受理</title>
    <updated>2020-11-25T16:50:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/awIZwslrMmC1JgKgePqTNg</id>
    <link href="https://mp.weixin.qq.com/s/awIZwslrMmC1JgKgePqTNg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE 发布《药品审评中心补充资料工作程序（试行）》</title>
    <updated>2020-11-25T16:50:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/skpmcLHO_7DZPJJkdeTLAg</id>
    <link href="https://mp.weixin.qq.com/s/skpmcLHO_7DZPJJkdeTLAg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>10 亿重磅品种！国内首个 Bcl-2 抑制剂即将获批，百济、复星等 4 家企业抢先布局</title>
    <updated>2020-11-24T18:16:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/FK7gxME6AQyogkSdmocWCQ</id>
    <link href="https://mp.weixin.qq.com/s/FK7gxME6AQyogkSdmocWCQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>刚刚！高值耗材第二批集采新动向来了，涉及 6 大类</title>
    <updated>2020-11-24T18:16:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/jTVEUAv4_TXWnsbZlGgI9Q</id>
    <link href="https://mp.weixin.qq.com/s/jTVEUAv4_TXWnsbZlGgI9Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>豪森药业 2 款仿制药报上市，国内暂无企业获批</title>
    <updated>2020-11-24T18:16:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/_P1_h5FuyCRQpRbHZ_kmOQ</id>
    <link href="https://mp.weixin.qq.com/s/_P1_h5FuyCRQpRbHZ_kmOQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>拟突破性疗法！恒瑞卡瑞利珠+法米替尼联合，用于治疗宫颈癌</title>
    <updated>2020-11-24T18:16:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/bz1idgGGpx434I-bOx9khw</id>
    <link href="https://mp.weixin.qq.com/s/bz1idgGGpx434I-bOx9khw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>首仿！南京天晴「奥美沙坦酯氨氯地平片」即将获批</title>
    <updated>2020-11-24T18:16:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/DFTaeJRqLSsmL6_cylbJHw</id>
    <link href="https://mp.weixin.qq.com/s/DFTaeJRqLSsmL6_cylbJHw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>注意！这 85 个参比制剂未通过审议</title>
    <updated>2020-11-24T18:16:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/muJh2L07BGPybeIDnw6QyQ</id>
    <link href="https://mp.weixin.qq.com/s/muJh2L07BGPybeIDnw6QyQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【报名即将截止】最终议程大公开！3大主题论坛，35+话题覆盖抗体开发与工艺生产，40+生物药大咖邀您共聚金陵城！</title>
    <updated>2020-11-24T18:16:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/GUGA8Cnu039NJhpdhNzjrQ</id>
    <link href="https://mp.weixin.qq.com/s/GUGA8Cnu039NJhpdhNzjrQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>丁苯酞大卖！石药三季营收 192.15 亿元，研发投入 22.66 亿元，抗肿瘤药物全线大增</title>
    <updated>2020-11-23T18:13:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/nvtI4qEEC7ZSMs-1eJBKDw</id>
    <link href="https://mp.weixin.qq.com/s/nvtI4qEEC7ZSMs-1eJBKDw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>明天见！苏州生物药研发策略沙龙拍了拍你</title>
    <updated>2020-11-23T18:13:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/YziIWqWNmCXBvh1Raq-M8g</id>
    <link href="https://mp.weixin.qq.com/s/YziIWqWNmCXBvh1Raq-M8g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>南京圣和药业的 1 类新药「和乐布韦片」拟纳入优先审评</title>
    <updated>2020-11-23T18:13:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/wUTdckM-CWPkBQa_g4v5qA</id>
    <link href="https://mp.weixin.qq.com/s/wUTdckM-CWPkBQa_g4v5qA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>